GL1X · GenesisL1 explorer

Research workbench

Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors, part 2, lead-optimisation.

Analyse Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2Y0J
Type
protein
Length
628 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Camp and camp-inhibited cgmp 3', 5'-cyclic phosphodiesterase 10A
EC
3.1.4.17
UniProt
Q9Y233
Ligands
AXC, ZN, MG
Pockets
6 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 72% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCamp and camp-inhibited cgmp 3', 5'-cyclic phosphodiesterase 10A (EC 3.1.4.17)protein31472% helix, 0% strandQ9Y233

Ligands and binding sites

  • AXC · 5-(1H-benzimidazol-2-ylmethylsulfanyl)-2-methyl-[1,2,4]triazolo[1,5-c]quinazoline · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17500.740.7983AXC, MG
24440.710.8152AXC, MG
35630.660.7746empty
4970.520.8321empty
5860.370.7618empty

Interfaces

1 interface between chains.

  • A–B · 697 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 2Y0J · Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors, part… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.